EUVIMEDEUVIMED entdecken
ValidierungsstudieOpen Access · CC BY 4.0

Assessing the Validity and Acceptability of an Adult Quality of Life Questionnaire, the EORTC QLQ‐C30, for Adolescents With Cancer

Samantha C Sodergren, David Riedl iD, Jamal Hossain, Haneen Abaza iD, Amal Al-Omari iD, Carlota Aguilera Ordoñez, Andrea Artigas Ramiro, Chiara Besani, Jaques Van Heerden, Lisa Lyngsie Hjalgrim, Betty Illatopa, Hiroto Ishiki und 11 weitere

Cancer Medicine · 2026

DOI: 10.1002/cam4.71952 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Cancer Medicine, 2026. Verfasst von Samantha C Sodergren und 22 weiteren Autor:innen. Beteiligte Einrichtung: University of Southampton, Southampton, UK. Hauptthemen laut MEDLINE: Quality of Life, Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Organisation for Research and Treatment of Cancer.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The EORTC QLQ‐C30 (QLQ‐C30) is the most widely used cancer‐specific patient‐reported outcome questionnaire in adult clinical trials, but its suitability for adolescents who have distinct developmental needs is unclear. Adolescents with cancer are often underrepresented in clinical trials, and efforts are underway to improve their participation by lowering the age of entry. This study evaluated the QLQ‐C30's acceptability, reliability, validity and delivery preferences in adolescents with cancer across different languages and cultural backgrounds. Materials and Methods Adolescents aged 12–17 years, undergoing or having completed cancer treatment for curative or palliative intent, completed the QLQ‐C30 alongside the PedsQL Cancer Teen questionnaire and shared their feedback on relevance, ease of completion and preferred mode of administration (paper or electronic). Socio‐demographic and clinical data were recorded.

Results

Two hundred adolescents (mean age 14.5 years, standard deviation (SD) 1.6 years; 51.5% male) representing different cultures participated. The QLQ‐C30 required a mean 12 min to complete and was described as acceptable and easy to complete. Psychometric testing confirmed the QLQ‐C30 subscale structure with acceptable‐to‐good internal consistency (Cronbach's α 0.70–0.84), as well as good convergent and discriminant validity with PedsQL subscales. Comparisons of scores according to treatment intent and performance status demonstrated some support for known‐group validity. Over half (57%) adolescents preferred paper completion of questionnaires.

Conclusions

This study is the first to systematically evaluate the QLQ‐C30 in adolescents and establishes its acceptability and validity in this population, confirming it as a measure of choice for clinical trials involving adolescents and enabling robust life course‐based outcome assessment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Quality of LifeNeoplasmsHumansAdolescentMaleFemaleSurveys and QuestionnairesPsychometricsChildReproducibility of ResultsPatient Reported Outcome Measures

Stichwörter der Autor:innen

EORTC QLQ‐C30adolescentscancerpatient‐reported outcomespsychometric validationquality of life

Autor:innen und Institutionen

  • University of Southampton, Southampton, UK.
  • University Hospital of Psychiatry II, Medical University of Innsbruck, Innsbruck, Austria.
  • Ludwig Boltzmann Institute for Rehabilitation Research, Vienna, Austria.
  • King Hussein Cancer Center, Office of Scientific Affairs and Research, Amman, Jordan.
  • Vall d'Hebron University Hospital, Barcelona, Spain.
  • Hospital Niño Jesús, Madrid, Spain.

ORCID-Profile: David Riedl, Haneen Abaza, Amal Al-Omari, Lucas Moreno, Anne-Sophie Darlington

Förderung

  • European Organisation for Research and Treatment of Cancer

Zitieren

APA

Sodergren, S. C., Riedl, D., Hossain, J., Abaza, H., Al-Omari, A., Ordoñez, C. A., Ramiro, A. A., Besani, C., Van Heerden, J., Hjalgrim, L. L., Illatopa, B., Ishiki, H., Krishnamurthy, M. N., Moreno, L., Mottram, R., O'Toole, S., Pérez-Campdepadros, M., Roganovic, J., Salo, A., …, & EORTC Quality of Life Group (2026). Assessing the Validity and Acceptability of an Adult Quality of Life Questionnaire, the EORTC QLQ‐C30, for Adolescents With Cancer. Cancer Medicine. https://doi.org/10.1002/cam4.71952

Vancouver

Sodergren SC, Riedl D, Hossain J, Abaza H, Al-Omari A, Ordoñez CA, et al. Assessing the Validity and Acceptability of an Adult Quality of Life Questionnaire, the EORTC QLQ‐C30, for Adolescents With Cancer. Cancer Medicine. 2026. doi:10.1002/cam4.71952

BibTeX
@article{Sodergren2026,
  author = {Sodergren, Samantha C and Riedl, David and Hossain, Jamal and Abaza, Haneen and Al-Omari, Amal and Ordoñez, Carlota Aguilera and Ramiro, Andrea Artigas and Besani, Chiara and Van Heerden, Jaques and Hjalgrim, Lisa Lyngsie and Illatopa, Betty and Ishiki, Hiroto and Krishnamurthy, Manjunath Nookala and Moreno, Lucas and Mottram, Rebecca and O'Toole, Stephanie and Pérez-Campdepadros, Marta and Roganovic, Jelena and Salo, Anna and De Schepper, Caroline and Tighe, Mark P and Darlington, Anne-Sophie and EORTC Quality of Life Group, EORTC Quality of Life Group},
  title = {Assessing the Validity and Acceptability of an Adult Quality of Life Questionnaire, the EORTC QLQ‐C30, for Adolescents With Cancer},
  journal = {Cancer Medicine},
  year = {2026},
  doi = {10.1002/cam4.71952}
}
Kostenlos starten →